NASDAQ : AKBA
Akebia Therapeutics, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.7065 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 195.78M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Akebia Therapeutics, Inc. (AKBA) reported revenue of 219.06M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 219.06M | 236.20M | 160.18M | 194.62M | 292.48M | 211.65M |
| Cost of Revenue | 40.66M | 40.35M | 26.15M | 39.76M | 22.50M | 81.49M |
| Gross Profit | 178.40M | 195.84M | 134.03M | 154.86M | 269.99M | 130.16M |
| Selling, General & Admin | 113.79M | 107.48M | 106.55M | 100.23M | 138.60M | 174.14M |
| Research & Development | 70.46M | 62.36M | 37.65M | 63.08M | 129.99M | 147.85M |
| Amortization of Goodwill & Intangibles | 36.04M | 36.04M | 36.04M | 36.04M | ||
| Operating Expenses | 184.25M | 169.84M | 180.24M | 199.35M | 304.63M | 358.03M |
| Operating Income | -5.85M | 26.00M | -46.21M | -44.49M | -34.64M | -227.88M |
| Interest Expense | -17.34M | -24.18M | -18.18M | -6.03M | -15.69M | -20.02M |
| Interest & Investment Income | 66.00K | |||||
| Other Non Operating Income (Expenses) | 4.62M | -3.04M | -236.00K | 887.00K | 3.15M | 2.41M |
| EBT Excluding Unusual Items | -18.57M | -1.22M | -64.63M | -49.64M | -47.18M | -245.41M |
| Merger & Restructuring Charges | -1.95M | -58.00K | -181.00K | -15.93M | -21.57M | |
| Gain (Loss) on Sale of Investments | 15.00K | |||||
| Asset Writedown | -7.33M | -2.50M | -4.21M | -1.58M | -30.24M | -15.05M |
| Other Unusual Items | -517.00K | -524.00K | -868.80K | |||
| Pretax Income | -27.85M | -3.72M | -69.41M | -51.92M | -94.23M | -282.02M |
| Income Tax Expense | 1.82M | 1.62M | ||||
| Net Income | -29.67M | -5.34M | -69.41M | -51.92M | -94.23M | -282.02M |
| Net Income to Common | -29.67M | -5.34M | -69.41M | -51.92M | -94.23M | -282.02M |
| Shares Outstanding (Basic) | 266.77M | 257.16M | 210.95M | 187.47M | 182.78M | 165.95M |
| Shares Outstanding (Diluted) | 266.77M | 257.16M | 210.95M | 187.47M | 182.78M | 165.95M |
| EPS (Basic) | -0.11 | -0.02 | -0.33 | -0.28 | -0.52 | -1.70 |
| EPS (Diluted) | -0.11 | -0.02 | -0.33 | -0.28 | -0.52 | -1.70 |
| Free Cash Flow | 40.26M | 67.70M | -40.69M | -23.38M | -73.27M | -253.02M |
| Free Cash Flow Per Share | 0.15 | 0.26 | -0.19 | -0.12 | -0.40 | -1.52 |
| Gross Margin | 81.44% | 82.92% | 83.68% | 79.57% | 92.31% | 61.50% |
| Operating Margin | -2.67% | 11.01% | -28.85% | -22.86% | -11.84% | -107.67% |
| Profit Margin | -13.54% | -2.26% | -43.33% | -26.68% | -32.22% | -133.25% |
| Free Cash Flow Margin | 18.38% | 28.66% | -25.40% | -12.02% | -25.05% | -119.55% |
| EBITDA | -4.30M | 27.27M | -8.70M | -6.87M | 3.06M | -189.91M |
| EBITDA Margin | -1.96% | 11.55% | -5.43% | -3.53% | 1.04% | -89.73% |
| D&A For EBITDA | 1.55M | 1.27M | 37.50M | 37.63M | 37.70M | 37.97M |
| EBIT | -5.85M | 26.00M | -46.21M | -44.49M | -34.64M | -227.88M |
| EBIT Margin | -2.67% | 11.01% | -28.85% | -22.86% | -11.84% | -107.67% |
| Revenue as Reported | 219.06M | 236.20M | 160.18M | 194.62M | 292.48M | 211.65M |
| Advertising Expenses | 7.60M | 4.60M | 1.00M | 6.70M | 8.20M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 155.55M | 184.84M | 51.87M | 42.92M | 90.47M | 149.80M |
| Cash & Short-Term Investments | 155.55M | 184.84M | 51.87M | 42.92M | 90.47M | 149.80M |
| Receivables | 53.51M | 47.03M | 34.37M | 39.29M | 40.28M | 55.89M |
| Inventory | 13.02M | 15.61M | 16.24M | 15.69M | 21.57M | 36.63M |
| Prepaid Expenses | 4.03M | 14.49M | 15.62M | 28.83M | ||
| Restricted Cash | 1.71M | 1.70M | ||||
| Other Current Assets | 5.77M | 3.77M | 7.32M | 5.75M | 17.25M | |
| Total Current Assets | 229.55M | 252.96M | 113.83M | 118.15M | 185.18M | 271.15M |
| Property, Plant & Equipment | 7.31M | 4.88M | 10.42M | 16.05M | 34.37M | 40.61M |
| Goodwill | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M |
| Other Intangible Assets | 36.04M | 72.08M | 108.13M | |||
| Other Long-Term Assets | 53.75M | 59.68M | 37.38M | 12.42M | 5.37M | 50.42M |
| Total Assets | 349.66M | 376.56M | 220.67M | 241.70M | 356.05M | 529.35M |
| Accounts Payable | 9.42M | 21.18M | 15.18M | 14.63M | 18.02M | 33.59M |
| Accrued Expenses | 89.65M | 92.12M | 33.27M | 42.94M | 53.92M | 97.51M |
| Current Portion of Long-Term Debt | 36.93M | 19.02M | 4.31M | 19.55M | 32.00M | 97.54M |
| Current Portion of Leases | 1.01M | 3.55M | 5.40M | 4.49M | 4.74M | 4.80M |
| Current Unearned Revenue | 6.17M | 2.68M | 3.74M | 20.91M | ||
| Other Current Liabilities | 17.69M | 24.38M | 22.75M | 18.26M | 17.12M | 6.70M |
| Total Current Liabilities | 160.87M | 162.94M | 80.91M | 99.87M | 129.54M | 261.05M |
| Long-Term Debt | 156.85M | 176.21M | 175.47M | 111.29M | 91.56M | 53.08M |
| Long-Term Leases | 4.40M | 3.55M | 8.95M | 28.96M | 33.70M | |
| Long-Term Unearned Revenue | 43.30M | 43.30M | 21.47M | |||
| Other Long-Term Liabilities | 2.52M | 4.80M | 9.93M | 8.88M | 57.47M | 86.03M |
| Total Liabilities | 324.64M | 343.95M | 269.86M | 272.29M | 350.82M | 455.34M |
| Common Stock | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | 1.00K |
| Additional Paid-In Capital | 1.73B | 1.72B | 1.63B | 1.58B | 1.56B | 1.54B |
| Retained Earnings | -1.70B | -1.68B | -1.68B | -1.61B | -1.56B | -1.46B |
| Comprehensive Income & Other | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Shareholders' Equity | 25.02M | 32.61M | -49.19M | -30.58M | 5.23M | 74.01M |
| Total Liabilities & Equity | 349.66M | 376.56M | 220.67M | 241.70M | 356.05M | 529.35M |
| Total Debt | 199.19M | 198.78M | 188.73M | 144.28M | 157.27M | 189.13M |
| Net Cash (Debt) | -43.64M | -13.94M | -136.86M | -101.35M | -66.80M | -39.33M |
| Net Cash Per Share | -0.16 | -0.05 | -0.65 | -0.54 | -0.37 | -0.24 |
| Filing Date Shares Outstanding | 277.11M | 267.88M | 236.23M | 209.37M | 184.25M | 181.23M |
| Total Common Shares Outstanding | 271.74M | 265.42M | 224.85M | 194.58M | 184.14M | 177.00M |
| Working Capital | 68.69M | 90.02M | 32.92M | 18.28M | 55.65M | 10.10M |
| Book Value Per Share | 0.09 | 0.12 | -0.22 | -0.16 | 0.03 | 0.42 |
| Tangible Book Value | -34.03M | -26.43M | -108.23M | -125.67M | -125.90M | -93.16M |
| Tangible Book Value Per Share | -0.13 | -0.10 | -0.48 | -0.65 | -0.68 | -0.53 |
| Machinery | 5.85M | |||||
| Leasehold Improvements | 8.57M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -29.67M | -5.34M | -69.41M | -51.92M | -94.23M | -282.02M |
| Depreciation & Amortization | 1.55M | 1.27M | 37.50M | 37.63M | 37.70M | 37.97M |
| Loss (Gain) From Sale of Assets | -172.00K | |||||
| Asset Writedown & Restructuring Costs | 64.00K | 782.00K | 8.77M | |||
| Loss (Gain) From Sale of Investments | -15.00K | |||||
| Stock-Based Compensation | 13.31M | 11.28M | 7.78M | 9.32M | 17.85M | 22.73M |
| Provision & Write-off of Bad Debts | 718.00K | 1.48M | 876.00K | |||
| Other Operating Activities | 35.24M | 43.01M | 22.27M | 1.54M | -41.80M | 73.98M |
| Change in Accounts Receivable | 18.59M | -14.14M | 4.05M | 994.00K | 11.30M | -24.03M |
| Change in Inventory | -13.71M | -23.12M | -28.40M | -2.54M | 19.09M | -24.95M |
| Change in Accounts Payable | -3.60M | 3.08M | -1.36M | -5.24M | 1.50M | -11.73M |
| Change in Unearned Revenue | 637.00K | 2.68M | -3.74M | 4.65M | 1.82M | |
| Change in Other Net Operating Assets | 18.42M | 47.98M | -13.96M | -10.20M | -37.98M | -46.72M |
| Operating Cash Flow | 41.55M | 67.99M | -40.66M | -23.38M | -73.15M | -252.97M |
| Capital Expenditures | -1.29M | -291.00K | -33.00K | -114.00K | -59.00K | |
| Sale of Property, Plant & Equipment | 172.00K | |||||
| Sale (Purchase) of Intangibles | -10.81M | -7.81M | ||||
| Investment in Securities | 40.00M | |||||
| Investing Cash Flow | -12.10M | -7.93M | -33.00K | -114.00K | 39.94M | |
| Long-Term Debt Issued | 10.00M | 45.00M | ||||
| Long-Term Debt Repaid | -4.23M | -37.10M | -32.00M | -33.00M | ||
| Net Debt Issued (Repaid) | -5.85M | 5.77M | 7.90M | -32.00M | -33.00M | |
| Issuance of Common Stock | 4.65M | 68.36M | 43.03M | 6.79M | 7.60M | 88.95M |
| Other Financing Activities | -10.00M | -1.21M | -1.27M | 40.00M | 44.78M | |
| Financing Cash Flow | -11.20M | 72.93M | 49.66M | -25.21M | 14.60M | 133.73M |
| Net Cash Flow | 18.26M | 132.99M | 8.97M | -48.59M | -58.67M | -79.29M |
| Free Cash Flow | 40.26M | 67.70M | -40.69M | -23.38M | -73.27M | -253.02M |
| Free Cash Flow Margin | 18.38% | 28.66% | -25.40% | -12.02% | -25.05% | -119.55% |
| Free Cash Flow Per Share | 0.15 | 0.26 | -0.19 | -0.12 | -0.40 | -1.52 |
| Levered Free Cash Flow | 33.64M | 68.61M | 13.63M | 17.90M | -15.30M | -136.04M |
| Unlevered Free Cash Flow | 44.47M | 83.73M | 25.00M | 21.67M | -5.50M | -123.53M |
| Cash Interest Paid | 6.08M | 6.08M | 5.04M | 6.06M | 6.75M | 9.63M |
| Change in Working Capital | 20.32M | 16.47M | -39.68M | -20.73M | -1.44M | -105.61M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 195.78M | 427.24M | 414.54M | 233.60M | 106.15M | 395.41M |
| Enterprise Value | 239.42M | 459.80M | 483.72M | 300.84M | 120.51M | 362.55M |
| Last Close Price | 0.71 | 1.61 | 1.90 | 1.24 | 0.58 | 2.26 |
| Forward PE | 82.56 | 18.72 | 18.72 | 18.72 | 18.72 | |
| PS Ratio | 0.89 | 1.81 | 2.59 | 1.20 | 0.36 | 1.87 |
| PB Ratio | 7.67 | 13.10 | -8.43 | -7.64 | 20.30 | 5.34 |
| P/FCF Ratio | 4.86 | 6.31 | ||||
| P/OCF Ratio | 4.71 | 6.28 | ||||
| PEG Ratio | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | |
| EV/Sales Ratio | 1.09 | 1.95 | 3.02 | 1.55 | 0.41 | 1.71 |
| EV/EBITDA Ratio | 16.86 | 39.44 | ||||
| EV/EBIT Ratio | 17.68 | |||||
| EV/FCF Ratio | 5.95 | 6.79 | ||||
| Debt / Equity Ratio | 7.96 | 6.10 | -3.84 | -4.72 | 30.07 | 2.56 |
| Debt / EBITDA Ratio | 220.34 | 6.16 | 18.82 | |||
| Debt / FCF Ratio | 4.95 | 2.94 | ||||
| Net Debt / Equity Ratio | 1.74 | 0.43 | -2.78 | -3.31 | 12.77 | 0.53 |
| Net Debt / EBITDA Ratio | -10.16 | 0.51 | -15.73 | -14.76 | 21.86 | -0.21 |
| Net Debt / FCF Ratio | 1.08 | 0.21 | -3.36 | -4.33 | -0.91 | -0.15 |
| Asset Turnover | 0.63 | 0.79 | 0.69 | 0.65 | 0.66 | 0.36 |
| Inventory Turnover | 2.74 | 2.53 | 1.64 | 2.13 | 0.77 | 1.67 |
| Quick Ratio | 1.30 | 1.42 | 1.07 | 0.82 | 1.01 | 0.79 |
| Current Ratio | 1.43 | 1.55 | 1.41 | 1.18 | 1.43 | 1.04 |
| Return on Equity (ROE) | -109.38% | -237.83% | -175.37% | |||
| Return on Assets (ROA) | -1.05% | 5.44% | -12.49% | -9.30% | -4.89% | -24.27% |
| Return on Capital Employed (ROCE) | -3.10% | 12.20% | -33.10% | -31.40% | -15.30% | -84.90% |
| Earnings Yield | -15.74% | -1.25% | -16.74% | -22.23% | -88.77% | -71.32% |
| FCF Yield | 20.57% | 15.85% | -9.82% | -10.01% | -69.03% | -63.99% |
| Buyback Yield / Dilution | -15.07% | -21.91% | -12.53% | -2.56% | -10.14% | -19.85% |